UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes

Journal of thrombosis and haemostasis, 2007-08, Vol.5 (8), p.1666-1673

2007

Volltextzugriff (PDF)

Lepirudin in patients with heparin‐induced thrombocytopenia – results of the third prospective study (HAT‐3) and a combined analysis of HAT‐1, HAT‐2, and HAT‐3

Journal of thrombosis and haemostasis, 2005-11, Vol.3 (11), p.2428-2436

2005

Volltextzugriff (PDF)

Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia

Circulation (New York, N.Y.), 2003-10, Vol.108 (17), p.2062-2065

2003

Volltextzugriff (PDF)

Predonation finger lancet punctures: a potential risk factor for interdonor pathogen transmission in the blood donor clinic

Vox sanguinis, 2016-07, Vol.111 (1), p.3-7

2016

Volltextzugriff (PDF)

Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests

Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.2025-2031

2010

Volltextzugriff (PDF)

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients

Journal of critical care, 2020-12, Vol.60, p.249-252

2020

Volltextzugriff (PDF)

Motivational factors for blood donation in first‐time donors and repeat donors: a cross‐sectional study in West Pomerania

Transfusion medicine (Oxford, England), 2017-12, Vol.27 (6), p.413-420

2017

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range

Blood, 2000-08, Vol.96 (3), p.846-851

2000

Volltextzugriff (PDF)

Standardizing the freeze‐thaw preparation of growth factors from platelet lysate

Transfusion (Philadelphia, Pa.), 2017-04, Vol.57 (4), p.1058-1065

2017

Volltextzugriff (PDF)

Can we make the predonation screening process more effective?

ISBT science series, 2016-01, Vol.11 (S1), p.62-67

2016

Volltextzugriff (PDF)

Prophylactic platelet transfusions

Vox sanguinis, 2012-08, Vol.103 (2), p.159-176

2012

Volltextzugriff (PDF)

Patterns of blood use in Sweden from 2008 to 2017: A nationwide cohort study

Transfusion (Philadelphia, Pa.), 2020-11, Vol.60 (11), p.2529-2536

2020

Volltextzugriff (PDF)

Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies

Blood, 2004-11, Vol.104 (10), p.3072-3077

2004

Volltextzugriff (PDF)

Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia

European journal of haematology, 2006-05, Vol.76 (5), p.420-426

2006

Volltextzugriff (PDF)

Recombinant hirudin in clinical practice : Focus on lepirudin

Circulation (New York, N.Y.), 2001-03, Vol.103 (10), p.1479-1484

2001

Volltextzugriff (PDF)

Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of local functional tolerance

Cancer research (Chicago, Ill.), 2004-04, Vol.64 (8), p.2865-2873

2004

Volltextzugriff (PDF)

International Forum on Home‐Based Blood Transfusion: Responses

Vox sanguinis, 2022-04, Vol.117 (4), p.E44-E57

2022

Volltextzugriff (PDF)

S4A-03 SESSION 4A: GENERALITIES IN CRANIOSYNOSTOSIS – PART I A TRANSFUSION REGIMEN WITH SAME-DONOR PACKED RED BLOOD CELLS REDUCES EXPOSURE TO MULTIPLE BLOOD DONORS IN CRANIOSYNOSTOSIS SURGERY

Plastic and reconstructive surgery. Global open, 2019-08, Vol.7 (8S-2), p.43-43

2019

Volltextzugriff (PDF)

The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference population

Clinical biochemistry, 2017-12, Vol.50 (18), p.1198-1202

2017

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudin

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2000-08, Vol.14 (2), p.109-125

2000

Volltextzugriff (PDF)

Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance

Blood, 2000-10, Vol.96 (7), p.2373-2378

2000

Volltextzugriff (PDF)

Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet units

Transfusion and apheresis science, 2016-12, Vol.55 (3), p.333-337

2016

Volltextzugriff (PDF)

Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin

Journal of thrombosis and thrombolysis, 2000-11, Vol.10 Suppl 1 (1), p.47

2000

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia: Temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin

Chest, 2002-07, Vol.122 (1), p.37-42

2002

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature

Thrombosis and haemostasis, 2004-04, Vol.91 (4), p.719

2004

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(51)
Humans
(47)
Hematology
(26)
Heparin - Adverse Effects
(25)
Thrombocytopenia - Chemically Induced
(23)
Male
(22)
Biological And Medical Sciences
(21)
Female
(21)
Medical Sciences
(20)
Middle Aged
(18)
Heparin-Induced Thrombocytopenia
(14)
Adult
(13)
Aged
(13)
Anticoagulants - Adverse Effects
(13)
Cardiovascular System & Cardiology
(13)
Pharmacology. Drug Treatments
(13)
Peripheral Vascular Disease
(11)
Thrombocytopenia - Drug Therapy
(10)
Heparin
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(8)
Der Unfallchirurg
(4)
Vox Sanguinis
(4)
Anesthesiology
(3)
Deutsche Medizinische Wochenschrift
(3)
Journal Of Pain Research
(3)
Journal Of Thrombosis And Haemostasis
(3)
Circulation
(2)
European Journal Of Haematology
(2)
Historian
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes

Lepirudin in patients with heparin‐induced thrombocytopenia – results of the third prospective study (HAT‐3) and a combined analysis of HAT‐1, HAT‐2, and HAT‐3

Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia

Predonation finger lancet punctures: a potential risk factor for interdonor pathogen transmission in the blood donor clinic

Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients

Motivational factors for blood donation in first‐time donors and repeat donors: a cross‐sectional study in West Pomerania

Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range

Standardizing the freeze‐thaw preparation of growth factors from platelet lysate

Can we make the predonation screening process more effective?

Prophylactic platelet transfusions

Patterns of blood use in Sweden from 2008 to 2017: A nationwide cohort study

Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies

Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia

Recombinant hirudin in clinical practice : Focus on lepirudin

Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of local functional tolerance

International Forum on Home‐Based Blood Transfusion: Responses

S4A-03 SESSION 4A: GENERALITIES IN CRANIOSYNOSTOSIS – PART I A TRANSFUSION REGIMEN WITH SAME-DONOR PACKED RED BLOOD CELLS REDUCES EXPOSURE TO MULTIPLE BLOOD DONORS IN CRANIOSYNOSTOSIS SURGERY

The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference population

Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudin

Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance

Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet units

Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin

Heparin-induced thrombocytopenia: Temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin

Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature

Suchergebnisse filtern